• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Natco Pharma Limited — Board Meeting, 14-11-2025: Outcome of Board Meeting

    14-11-2025 | 01:27 pm

    NATCO Pharma's board approved Q2 & H1 FY26 consolidated financial results, with Q2 revenue at ₹1,363 Cr and net profit at ₹517.9 Cr. They declared a ₹1.50/share interim dividend and will incorporate a new subsidiary for the Crop Health Sciences demerger.

    No comments yet. Be the first to comment!

    All announcements from Natco Pharma Limited